Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTCy for GVHD Prophylaxis in MMUD HCT
NCT03128359Phase 2Completed
- Sponsor
- City of Hope
- Start
- May 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by City of Hope. Started May 2017; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03128359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03128359.